# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ernest Shackleton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX001-SYN
- Date: 2026-05-26
- Fictional facility: St. Posthumous Health Center
- Fictional author: Cormac Ellingsworth-Daly, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week follow-up of exertional chest tightness, seen the same day by cardiology after coronary CT angiography. **S**

## History of present illness

Mr. Shackleton returns two weeks after his first visit, on the day of his cardiology consultation with Dr. Solberg-Adebayo, after coronary CT angiography and an echocardiogram this morning. He stopped smoking on his quit date a week ago and is taking varenicline, with mild nausea after the morning dose that eases with food. The chest tightness comes less often on metoprolol, but still comes two or three times a week on the stairs to his office or when he carries a load, and passes within three minutes of rest. He used nitroglycerin twice, with relief within two minutes. He has had no pain at rest, fainting, or palpitations. He is taking aspirin and atorvastatin every day. He has cut down to two drinks on most evenings. He wanted to know whether any of this would be reported to the expedition's backers; he was told it would not, without his consent. **S**

| Element | Detail |
|---|---|
| Angina | Two or three episodes a week with stairs or loads; relieved by rest |
| Nitroglycerin | Used twice, effective |
| Tobacco | Not smoked for a week; varenicline with mild nausea |
| Alcohol | Two drinks on most evenings |
| Red flags | No rest pain, fainting, or palpitations |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Positive | Exertional chest tightness, less often; no rest pain, palpitations, or ankle swelling |
| Respiratory | Positive | Breathless with the chest tightness only; morning cough less |
| Gastrointestinal | Positive | Mild nausea after the morning varenicline dose |
| Psychiatric | Negative | Sleeping well; no low mood, agitation, or unusual dreams troubling him |

4 systems reviewed. **S**

## Current medications

- Aspirin 81 mg delayed-release tablet, one tablet by mouth daily **S**
- Atorvastatin 80 mg tablet, one tablet by mouth daily **S**
- Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeat every 5 minutes up to 3 doses **S**
- Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration **S**
- Metoprolol succinate extended-release 100 mg tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 134/84 mmHg; pulse 66 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 85.6 kg; BMI 28 kg/m². All vital signs are synthetic.

LVEF: 58%. All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 134/84, pulse 66, weight 85.6 kg |
| Cardiovascular | Regular rhythm; normal heart sounds; no murmur; no carotid bruits; no edema |
| Respiratory | Clear to auscultation bilaterally |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Chronic coronary disease with stable exertional angina** (I25.118). The presenting exertional chest tightness now has its cause. Coronary CT angiography this morning shows an 80% stenosis of the proximal left anterior descending artery with a CT-derived fractional flow reserve of 0.70, a 30% plaque in the right coronary artery, and a coronary calcium score of 210. The echocardiogram is normal, with LVEF 58%, normal wall motion and valves, and no interatrial shunt on the agitated-saline study. Angina is less frequent on metoprolol 50 mg but still limits him (Canadian Cardiovascular Society class II). Dr. Solberg-Adebayo recommends a higher beta-blocker dose first and revascularization if angina persists. **S**
   - Metoprolol succinate up to 100 mg daily.
   - Continue aspirin, atorvastatin 80 mg, and nitroglycerin as needed.
   - Review in four weeks: if angina persists, discuss coronary angiography and a stent.
   - Lipid panel at ten weeks.
2. **Nicotine dependence, cigarettes** (F17.210). Not smoked for a week since his quit date; nausea on varenicline is mild. **S**
   - Take varenicline with food and a full glass of water.
   - Counseling call each week.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure (target below 130/80 mmHg) | Every visit | Completed today | 134/84 mmHg, above target; expected to fall with the higher metoprolol dose |
| Examination | Weight, BMI, and physical activity | Every visit | Completed today | 85.6 kg, BMI 28.0; no regular exercise yet |
| Examination | Angina frequency and Canadian Cardiovascular Society class, nitroglycerin use | Every visit | Completed today | Two or three episodes a week (class II); nitroglycerin twice |
| Imaging | Coronary CT angiography with CT-FFR as the first test for suspected obstructive coronary disease | Once, at diagnosis | Completed today | 80% proximal LAD stenosis with CT-FFR 0.70; 30% RCA plaque; calcium score 210 |
| Imaging | Echocardiogram at diagnosis | Once at diagnosis, then only with a change in status | Completed today | LVEF 58%; normal wall motion and valves; no shunt |
| Medication safety | Adherence review: aspirin (or dual antiplatelet therapy), high-intensity statin, beta-blocker for angina | Every visit | Completed today | Aspirin, atorvastatin, and metoprolol taken daily; metoprolol raised to 100 mg |
| Laboratory | Lipid panel | 4 to 12 weeks after starting or changing lipid therapy, then every 3 to 12 months | Due | Atorvastatin 80 mg started two weeks ago; lipid panel at ten weeks |
| Laboratory | HbA1c for prediabetes | Every 3 to 6 months while lifestyle change is under way, then yearly | Up to date | 5.9% at intake |
| Self-management | Tobacco use and cessation support (varenicline with counseling) | Every visit | Completed today | Abstinent since the quit date a week ago; mild nausea on varenicline |
| Survey | Alcohol use (AUDIT-C) and brief intervention | At intake, then each visit until within limits | Up to date | AUDIT 12 at intake with a brief intervention; now two drinks on most evenings |
| Survey | Depression screen (PHQ-2, then PHQ-9 if positive) | Periodically | Up to date | PHQ-2 1 at intake |
| Referral | Cardiology consultation | At diagnosis | Completed today | Seen by Dr. Solberg-Adebayo today |
| Referral | Cardiac rehabilitation referral | At diagnosis of stable angina, and after PCI | Deferred | Recommended by cardiology today but not placed; the referral was held until the decision about revascularization. The protocol calls for a referral at the diagnosis of stable angina |
| Self-management | Remote expedition plan (exercise test, medicines, defibrillator, evacuation, cold stress) | Before departure | Ordered | Pre-departure exercise test and expedition plan agreed with cardiology |

## Goal progress

- No cigarettes from the quit date, confirmed at each visit. In progress; target 2026-09-08. **S**
- LDL cholesterol below 55 mg/dL with at least a 50% reduction by four months. In progress; target 2026-09-08. **S**
- Blood pressure below 130/80 mmHg by six weeks. In progress; target 2026-06-23. **S**
- Free of angina in daily activity, and a symptom-limited exercise test of at least 10 METs without ischemia before departure. In progress; target 2026-09-08. **S**
- Drinking within the low-risk limit, with an AUDIT-C below 4, by four months. In progress; target 2026-09-08. **S**
- At least 15 sessions of cardiac rehabilitation before departure. In progress; target 2026-09-08. **S**

## Medication changes

- Stopped: Metoprolol succinate extended-release 50 mg tablet, one tablet by mouth daily **S**
- Started: Metoprolol succinate extended-release 100 mg tablet, one tablet by mouth daily **S**

## Guideline basis

- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023), American Heart Association and American College of Cardiology
- 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024), European Society of Cardiology
- CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026), Aether Forge
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force

## Follow-up

- Review in four weeks. Call emergency services for chest pain that lasts more than 5 minutes after one nitroglycerin, or pain at rest. **S**
- Next scheduled visit 2026-06-23: six-week review: angina on medical therapy, smoking, and a shared decision about coronary angiography and stenting. **S**
